Kreuzer Martin, Gähler Dagmar, Rakenius Annette C, Prüfe Jenny, Jack Thomas, Pfister Eva-Doreen, Pape Lars
Department of Paediatric Nephrology, Hepatology and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Department of Paediatric Cardiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Pediatr Nephrol. 2015 Dec;30(12):2199-206. doi: 10.1007/s00467-015-3156-9. Epub 2015 Aug 1.
Acute kidney injury (AKI) is a major complication in children with hepatic failure which leads to increased morbidity and mortality. The aim of this study was to provide paediatric data on the prevalence of dialysis-dependent AKI (dAKI), the feasibility and efficacy of dialysis methods and outcome.
We conducted a retrospective analysis of 367 children listed for orthotopic liver transplantation (OLT) in our centre during the past decade.
Data on 30 children (15 boys, 15 girls) were compiled for retrospective analysis, and data on dialysis feasibility and efficacy were available for 26 of these. Median age was 3.5 (range 0.4-17.7) years. Median MELD (Model For End-Stage Liver Disease) score was 33. dAKI was caused by hepato-renal syndrome in 16 of the 30 children. Twenty-one patients were treated with continuous veno-venous haemofiltration (CVVH), and nine patients received peritoneal dialysis (PD). Overall mortality was 77%. Mortality within the PD-group was 100 % versus 67% in the CVVH-group (p = 0.039). Urea reduction rate within the first 24 h of treatment was 12.9% in the PD group and 23.5% in the CVVH group (p = 0.019).
Children with end-stage liver disease have a high risk for dAKI associated with high mortality. CVVH is associated with better efficacy and less mortality than PD.
急性肾损伤(AKI)是肝功能衰竭患儿的主要并发症,会导致发病率和死亡率上升。本研究的目的是提供关于依赖透析的急性肾损伤(dAKI)患病率、透析方法的可行性和有效性以及预后的儿科数据。
我们对过去十年在本中心登记接受原位肝移植(OLT)的367名儿童进行了回顾性分析。
收集了30名儿童(15名男孩,15名女孩)的数据进行回顾性分析,其中26名儿童有透析可行性和有效性的数据。中位年龄为3.5岁(范围0.4 - 17.7岁)。中位终末期肝病模型(MELD)评分为33分。30名儿童中有16名的dAKI由肝肾综合征引起。21例患者接受了连续性静脉 - 静脉血液滤过(CVVH)治疗,9例患者接受了腹膜透析(PD)。总体死亡率为77%。PD组的死亡率为100%,而CVVH组为67%(p = 0.039)。治疗后第1个24小时内,PD组的尿素清除率为12.9%,CVVH组为23.5%(p = 0.019)。
终末期肝病患儿发生dAKI的风险高,且死亡率高。与PD相比,CVVH疗效更好,死亡率更低。